Company to convert incremental 550,000 sq. ft. of advanced greenhouse to cannabis production Phased expansion plan expected to provide additional 40 tonnes of annual production once complete Increased capacity will support continued profitable growth in Canadian and International markets VANCOUVER, British Columbia, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ: VFF) today announced that its Board of Directors has unanimously approved an inves ...

Group 1 - Alan Brochstein is a pioneer in the cannabis investment sector, having focused exclusively on this industry since 2007 [1] - He founded AB Analytical Services to provide independent consulting to registered investment advisors [1] - Alan is the managing partner of New Cannabis Ventures, which has been a key provider of financial information in the cannabis industry since 2015 [1] Group 2 - Alan has led the investing group 420 Investor since 2013, which focuses on publicly-traded cannabis stocks [2] - The group covers 20 stocks, providing investment news, earnings report previews, and post-report analyses [2] - Additional features of the group include a model portfolio, 10 weekly videos with chart analysis, 3 weekly summary pieces, a monthly newsletter, and a chat for questions [2]

Core Insights - Tilray Brands reported its fourth-quarter results for fiscal 2025, with earnings exceeding estimates but sales falling short, both declining compared to the previous year [1][10] - Adjusted EPS was 2 cents, down 50% year over year, while revenues decreased by 2% to $224.5 million, primarily due to weak performance in cannabis and beverages [2] - The company expects adjusted EBITDA for fiscal 2026 to be between $62 million and $72 million, indicating a growth of 13-31% over the prior year [3] Financial Performance - Fiscal 2025 revenues reached $821 million, a 4% increase year over year, largely driven by non-cannabis business diversification [4] - Non-cannabis segments accounted for approximately 70% of total sales, with beverages contributing 29%, distribution 33%, and wellness 8% [5] - Beverage sales rose 19% year over year to $240.6 million, despite SKU rationalization efforts [6] Market Position and Strategy - Tilray has established a strong presence in the hemp market, holding nearly 60% branded market share in the U.S. and 80% in Canada [7] - The company is focusing on enhancing its global supply chain and cultivation footprint to meet growing demand, with expectations of benefiting from Project 420 in the second half of fiscal 2026 [8] - The cannabis segment saw a 9% decline in revenues to $249 million, with international cannabis sales growing 19%, although still a small portion of total cannabis sales [11] Competitive Landscape - Tilray faces intense competition from peers like Aurora Cannabis, Canopy Growth, and Curaleaf Holdings, all pursuing international expansion and cost optimization [12] - The company's stock has dropped 56% year to date, contrasting with a 6% growth in the industry, reflecting ongoing financial challenges and uncertainty around U.S. marijuana legalization [13] Investment Considerations - While Tilray's diversification into craft beverages and THC drinks shows strategic foresight, the decline in its core cannabis business and competitive pressures remain significant near-term challenges [15]

Core Insights - Curaleaf Holdings, Inc. has opened a new medical cannabis dispensary in St. Augustine, Florida, increasing its store count to 68 in Florida and 154 nationwide [1][4] Group 1: Store Opening Details - The new dispensary is located at 1280 Ponce De Leon Blvd., St. Augustine, FL 32084, and will start serving medical patients on August 1, 2025 [1] - Curaleaf St. Augustine is strategically positioned near downtown shops, dining, and cultural attractions, enhancing accessibility for patients [2] Group 2: Product Offerings - The dispensary will offer a wide range of medical cannabis products, including the new Grassroots Dark Heart Collection, Select brand vapes and edibles, Florida-exclusive flower brand Reef, and Anthem pre-rolls [2][3] - Curaleaf has introduced a 72-hour Flower Satisfaction Guarantee for premium eighths purchased from Grassroots and Reef brands, allowing patients to return unsatisfactory products for store credit or exchange [3] Group 3: Company Commitment and Expansion - Curaleaf's Chairman and CEO, Boris Jordan, emphasized the company's commitment to enhancing flower quality and patient access to trusted products [3] - The grand opening celebration for Curaleaf St. Augustine is scheduled for August 8, 2025, featuring various activities to engage the community [4]

Industry Overview - Cannabis industry possesses significant untapped potential despite challenges [1] Career Opportunities - The report explores high-paying job opportunities within the cannabis industry [1] - The report provides guidance on how to secure these high-paying positions [1]

Business Strategy - Tilray is now focusing on the beer industry [1] - The company is shifting away from being solely a cannabis company [1]

Core Viewpoint - Rubicon Organics Inc. held its Annual General and Special Meeting, where shareholders approved all proposed matters, including board appointments and an amended Omnibus Equity Incentive Plan [1][2][3]. Shareholder Meeting Results - A total of 31,130,021 shares were represented, constituting approximately 46.3% of the total issued and outstanding common shares [2]. - The shareholders approved the following key matters: - Setting the number of directors at eight [7]. - Electing Doris Bitz, Len Boggio, Margaret Brodie, Michael Detlefsen, Ian Gordon, Jesse McConnell, John Pigott, and Karen Proud as directors [7]. - Appointing PricewaterhouseCoopers LLP as the Company's auditors [7]. - Approval of the amended Omnibus Equity Incentive Plan with 74.7% in favor [4]. Board Changes - Len Boggio stepped down as Chair of the Board and transitioned to Chair of the Nomination and Governance Committee [5]. - Doris Bitz was appointed as the new Chair, bringing over 30 years of experience in manufacturing and consumer packaged goods [6][8]. Omnibus Equity Incentive Plan - The amended Omnibus Equity Incentive Plan allows for the issuance of various equity awards, with a maximum of 8,960,180 common shares available for grants [9][10]. - An aggregate of 1,024,576 Deferred Share Units (DSUs) was granted to independent directors as compensation for the next 12 months [11]. Company Overview - Rubicon Organics is a leader in certified organic and premium cannabis in Canada, with a vertically integrated model and strong national distribution [12]. - The company has expanded its production capacity by over 40% with the acquisition of the Hope, BC Facility, supporting growth in domestic and export markets [13]. - The focus on premium quality, innovation, and operational execution has driven consistent revenue growth and positive Adjusted EBITDA [14].

Core Points - IM Cannabis Corp. has successfully closed a private placement offering, raising gross proceeds of approximately C$5,622,522 (around US$4,100,000) by issuing 2,050,000 units at a price of C$2.7427 per unit [1] - Each unit consists of one common share or one pre-funded common share purchase warrant and one common share purchase warrant, with the latter allowing the purchase of shares at C$3.43 for a period of 60 months [2] - The proceeds from the offering will be used for general working capital, repayment of existing debt, and other corporate purposes [6] Company Overview - IM Cannabis Corp. is a leading medical cannabis company operating in Israel and Germany, focusing on providing premium cannabis products to medical patients [7] - The company utilizes a data-driven approach and a globally sourced product supply chain to enhance its operations and compliance with regulatory standards [7] - In Israel, the company imports and distributes cannabis, operates medical cannabis retail pharmacies, and manages logistical hubs to ensure quality control [8] - In Germany, IM Cannabis operates through Adjupharm GmbH, distributing cannabis to pharmacies for medical patients [9]

Core Points - SNDL Inc. announced that all resolutions put to shareholders at the Annual and Special Meeting were passed [1] Group 1: Shareholder Meeting Resolutions - Shareholders approved fixing the number of directors at seven [2] - The following individuals were elected as directors: Gregory Mills, J. Carlo Cannell, Lori Ell, Zachary George, Frank Krasovec, Bryan Pinney, and Gregory Turnbull [2] - CBIZ Inc. was re-appointed as the auditors for the ensuing year, with the board authorized to set their remuneration [2] - Approval was granted for the Company's Stock Option Plan and Restricted and Performance Share Unit Plan, including unallocated awards [2] Group 2: Voting Results - The vote for fixing the number of directors received 81,437,840 votes for (90.08%) and 8,966,964 votes against (9.92%) [3] - Individual director nominees received the following votes: - Gregory Mills: 37,627,605 votes for (90.43%) - J. Carlo Cannell: 37,674,260 votes for (90.55%) - Lori Ell: 37,669,902 votes for (90.54%) - Zachary George: 37,596,461 votes for (90.36%) - Frank Krasovec: 37,291,964 votes for (89.63%) - Bryan Pinney: 37,589,021 votes for (90.34%) - Gregory Turnbull: 37,132,554 votes for (89.24%) [3] - The re-appointment of CBIZ Inc. as auditors received 81,759,588 votes for (90.44%) and 8,645,217 votes withheld (9.56%) [4] - Approval for the Stock Option Plan and Restricted and Performance Share Unit Plan received 34,749,681 votes for (83.52%) and 6,857,761 votes against (16.48%) [4] Group 3: Company Overview - SNDL Inc. is one of the largest vertically integrated cannabis companies in Canada and the largest private-sector liquor and cannabis retailer [4] - The company operates retail banners including Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf, and Superette [4] - SNDL's consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Grön, No Future, and Bhang Chocolate [4] - The investment portfolio aims to deploy strategic capital through direct and indirect investments and partnerships in the North American cannabis industry [4]

Core Insights - Investor interest in cannabis stocks has decreased since the legalization boom of 2021, but Tilray Brands is positioning itself uniquely in the market [1] Financial Performance - Tilray ended fiscal 2025 with record revenue of $821 million, driven by its cannabis, beverage, and wellness divisions [2] - The company reported a headline GAAP loss of $2.1 billion for the year, primarily due to a non-cash goodwill write-down, but posted a modest adjusted profit and improved cannabis gross margins by 700 basis points [5] Business Strategy - Tilray is combining its cannabis, beverage, and wellness businesses, leveraging its U.S. distribution network from craft beer acquisitions to roll out hemp-derived THC drinks, which are available in 13 states at approximately 1,300 locations [3][4] - Unlike competitors, Tilray is the only scaled player integrating cannabis cultivation, beverage production, and wellness under one roof [4] Market Position and Opportunities - The company has a multi-pronged strategy that provides resilience against market fluctuations; if cannabis sales lag, it can rely on its beer portfolio and hemp drinks [6] - Future catalysts for Tilray include U.S. federal cannabis reform, state-level changes in THC beverage regulations, and potential further acquisitions in the craft beer sector, which could provide a first-mover advantage [7] Unique Selling Proposition - Tilray's approach to connecting cannabis, beverages, and wellness could differentiate it in the market, making it a company to watch for long-term investors [8]